Windtree Therapeutics Faces Nasdaq Delisting Amid Compliance Failures

BTCC / BTCC Square / Global Cryptocurrency /

Author:

Release Time:

2025-08-21 09:53:02

BTCCSquare news:

Nasdaq has initiated delisting proceedings against Windtree Therapeutics (WINT) for failing to maintain a minimum bid price of $1 per share, as mandated by its Listing Rule 5550(a)(2). Trading will halt on August 21, 2025, though the company vows to continue meeting regulatory reporting requirements.

Windtree's shares have collapsed over 99% year-to-date, closing at $0.11 before the suspension. The biopharma firm follows Bitcoin miner Argo Blockchain, which faced similar Nasdaq delisting actions in July for sub-$1 trading.

Notably, Windtree gained attention for its cryptocurrency investments, though the article cuts off before detailing specific digital asset exposures. The delisting reflects broader market pressures on small-cap firms struggling with compliance thresholds.

By:

Log in to Reply

Federal Reserve Explores Tokenization and AI for Modernizing Payment Systems

Articles on this site are sourced from public networks or curated by AI for informational purposes only and do not represent BTCC’s views. Original rights belong to the respective authors. For copyright concerns, please contact [email protected]. BTCC assumes no liability for the accuracy, timeliness, or completeness of this information, and disclaims all liability arising from reliance on such content. This content is for reference only and should not be taken as investment, legal, or commercial advice.